Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19

NCT04347681 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
575
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

King Fahad Specialist Hospital Dammam

Collaborators